175 related articles for article (PubMed ID: 417031)
1. Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa.
Snell K; Holder IA; Leppla SA; Saelinger CB
Infect Immun; 1978 Mar; 19(3):839-45. PubMed ID: 417031
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of Pseudomonas aeruginosa exotoxin A in experimental mouse infections: adenosine diphosphate ribosylation of elongation factor 2.
Pavlovskis OR; Iglewski BH; Pollack M
Infect Immun; 1978 Jan; 19(1):29-33. PubMed ID: 415004
[TBL] [Abstract][Full Text] [Related]
3. Protective activity of anti-exotoxin A monoclonal antibody against mice infected with toxin-producing Pseudomonas aeruginosa.
Kohzuki T; Eguchi Y; Kato M; Irie K; Ohtsuka H; Higuchi A; Noguchi H
J Infect Dis; 1993 Jan; 167(1):119-25. PubMed ID: 8418158
[TBL] [Abstract][Full Text] [Related]
4. Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.
Pavlovskis OR; Pollack M; Callahan LT; Iglewski BH
Infect Immun; 1977 Dec; 18(3):596-602. PubMed ID: 412786
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence.
O'Callaghan RJ; Engel LS; Hobden JA; Callegan MC; Green LC; Hill JM
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):534-43. PubMed ID: 8595953
[TBL] [Abstract][Full Text] [Related]
6. Role of exotoxin A and proteases of Pseudomonas aeruginosa in respiratory tract infections.
Baker NR
Can J Microbiol; 1982 Feb; 28(2):248-55. PubMed ID: 6802477
[TBL] [Abstract][Full Text] [Related]
7. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
Wretlind B; Pavlovskis OR
Scand J Infect Dis Suppl; 1981; 29():13-9. PubMed ID: 6797058
[TBL] [Abstract][Full Text] [Related]
8. Experimental infections with protease-deficient mutants of Pseudomonas aeruginosa in mice.
Wretlind B; Kronevi T
J Med Microbiol; 1978 May; 11(2):145-54. PubMed ID: 96256
[TBL] [Abstract][Full Text] [Related]
9. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors.
Holder IA; Haidaris CG
Can J Microbiol; 1979 May; 25(5):593-9. PubMed ID: 89891
[TBL] [Abstract][Full Text] [Related]
10. Combined host and specific anti-Pseudomonas-directed therapy for Pseudomonas aeruginosa infections in burned mice: experimental results and theoretic considerations.
Holder IA; Neely AN
J Burn Care Rehabil; 1989; 10(2):131-7. PubMed ID: 2496130
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of monoclonal antibodies to exotoxin A from Pseudomonas aeruginosa.
Galloway DR; Hedstrom RC; Pavlovskis OR
Infect Immun; 1984 May; 44(2):262-7. PubMed ID: 6425217
[TBL] [Abstract][Full Text] [Related]
12. Experimental studies on the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence for toxin production during Pseudomonas infection of burned skin tissues.
Saelinger CB; Snell K; Holder IA
J Infect Dis; 1977 Oct; 136(4):555-61. PubMed ID: 409788
[TBL] [Abstract][Full Text] [Related]
13. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: effect of treatment with protease inhibitors.
Holder IA
Rev Infect Dis; 1983; 5 Suppl 5():S914-21. PubMed ID: 6197736
[TBL] [Abstract][Full Text] [Related]
14. Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.
Pavlovskis OR; Edman DC; Leppla SH; Wretlind B; Lewis LR; Martin KE
Infect Immun; 1981 May; 32(2):681-9. PubMed ID: 6788700
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas keratitis: protease IV gene conservation, distribution, and production relative to virulence and other Pseudomonas proteases.
Caballero A; Thibodeaux B; Marquart M; Traidej M; O'Callaghan R
Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):522-30. PubMed ID: 14744894
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of infections owing to Pseudomonas aeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati.
Holder IA
Can J Microbiol; 1985 Apr; 31(4):393-402. PubMed ID: 3924388
[No Abstract] [Full Text] [Related]
17. Interaction of pseudomonas exoproducts with phagocytic cells.
Weber B; Nickol MM; Jagger KS; Saelinger CB
Can J Microbiol; 1982 Jun; 28(6):679-85. PubMed ID: 6811122
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.
Klinger JD; Straus DC; Hilton CB; Bass JA
J Infect Dis; 1978 Jul; 138(1):49-8. PubMed ID: 98596
[TBL] [Abstract][Full Text] [Related]
19. Characteristics, isolation and role in the infectious process of Pseudomonas aeruginosa protease.
Brodinova NS; Moroz AF; Luchina TYa
J Hyg Epidemiol Microbiol Immunol; 1983; 27(1):69-76. PubMed ID: 6406591
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas deficient in protease IV has significantly reduced corneal virulence.
Engel LS; Hobden JA; Moreau JM; Callegan MC; Hill JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1535-42. PubMed ID: 9224281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
